Drugs Experience for Adolescents With Anorexia
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age12+
SponsorAssistance Publique - Hôpitaux de Paris
About this trial
The purpose of this study is to access to the experiences of adolescents, their parents and healthcare professionals regarding psychotropic drugs in anorexia nervosa.
No preconceived ideas (according to qualitative methods) but a question: what are the participants' perceptions and experiences of psychotropic drugs in anorexia nervosa? In an adolescent medicine department.
Eligibility criteria
Qualifiers
Aged 12 to 25 years
Suffering from anorexia nervosa (restrictive or mixed) according to DSM-5 (Diagnostic and Statistical Manual) criteria
Received psychotropic drugs (antidepressant treatment and/or APA) during their care, either ongoing or discontinued before this study started
Disqualifiers
Atypical eating disorder that does not meet the DSM-5 criteria for restrictive or mixed anorexia nervosa
BMI<15
Prescription of an antidepressant other than an SSRI (Selective Serotonin Reuptake Inhibitor)
Prescription of an APA for the indication of psychotic symptoms
Trial design
Treatments tested in this trial
- Semi-structured interviews with visual mediations
- Semi-structured interviews
Treatment groups
90 Participants
are divided into 3 treatment groupsSponsors and collaborators
Assistance Publique - Hôpitaux de Paris
Lead sponsor
URC-CIC Paris Descartes Necker Cochin
Collaborator
Source ClinicalTrials.gov